ST Pharm Co.Ltd (237690) — Financial Flexibility Index
ST Pharm Co.Ltd (237690) has a Financial Flexibility Index of -0.08x as of December 2025. Free cash flow of ₩-15.27 Billion (operating CF ₩-21.16 Billion minus capex ₩5.89 Billion) represents 0% of total liabilities (₩189.56 Billion). Check 237690 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ST Pharm Co.Ltd Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for ST Pharm Co.Ltd across 11 annual periods. See ST Pharm Co.Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for ST Pharm Co.Ltd (2015–2025)
Year-by-year free cash flow to debt coverage for ST Pharm Co.Ltd. For the full company profile including market capitalisation, see ST Pharm Co.Ltd stock valuation.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.32x | ₩61.27 Billion | ₩13.99 Billion | ₩189.56 Billion | ▼ -63.3% |
| 2024 | 0.88x | ₩192.68 Billion | ₩109.45 Billion | ₩218.88 Billion | ▲ +467.7% |
| 2023 | 0.16x | ₩44.74 Billion | ₩1.30 Billion | ₩288.53 Billion | ▼ -46.6% |
| 2022 | 0.29x | ₩67.69 Billion | ₩7.03 Billion | ₩233.02 Billion | ▼ -13.6% |
| 2021 | 0.34x | ₩59.06 Billion | ₩7.27 Billion | ₩175.59 Billion | ▲ +1380.8% |
| 2020 | -0.03x | ₩-3.95 Billion | ₩-20.93 Billion | ₩150.24 Billion | ▲ +95.7% |
| 2019 | -0.61x | ₩-24.30 Billion | ₩-30.52 Billion | ₩40.12 Billion | ▼ -122.2% |
| 2018 | 2.72x | ₩37.93 Billion | ₩10.77 Billion | ₩13.94 Billion | ▲ +0.8% |
| 2017 | 2.70x | ₩82.13 Billion | ₩54.44 Billion | ₩30.42 Billion | ▲ +120.4% |
| 2016 | 1.23x | ₩66.81 Billion | ₩50.78 Billion | ₩54.53 Billion | ▲ +121.0% |
| 2015 | 0.55x | ₩58.22 Billion | ₩35.82 Billion | ₩105.04 Billion | — |